Welcome to our dedicated page for Tian Ruixiang Hldgs news (Ticker: TIRX), a resource for investors and traders seeking the latest updates and insights on Tian Ruixiang Hldgs stock.
TIAN RUIXIANG Holdings Ltd (NASDAQ: TIRX) is a Beijing-headquartered insurance broker that operates in China through a variable interest entity and distributes property, casualty, health, life, and other insurance products. The TIRX news feed highlights company announcements, strategic transactions, financial updates, and regulatory disclosures that shape the outlook for this insurance brokerage and its related businesses.
Investors and observers can use this page to follow TIAN RUIXIANG’s corporate developments, including its expansion into AI-enabled health insurance risk management through the acquisition of Ucare Inc., described as the operator of a cloud-based AI-driven hospital and health insurance risk management platform in China. News items also cover the company’s moves to diversify and globalize its operations via share exchange agreements to acquire BEYOND COASTLINE HOLDINGS LIMITED, a Southeast Asian new retail group focused on beauty and wellness holdings operations, and REN Talents Inc., a U.S.-based talent management and agency business described as a full-service creative brand agency.
The TIRX news stream includes capital markets and governance updates such as the pricing of registered direct offerings of Class A ordinary shares and warrants, the implementation of a five-to-one reverse stock split and related shareholder approvals, changes in the company’s independent auditor, and leadership transitions at the board and chief executive level. It also features financial reporting news, including half-year and full-year results, commentary on revenue trends in insurance commissions, and information on compliance with Nasdaq’s periodic filing requirements.
By reviewing the latest TIRX news, readers can track how TIAN RUIXIANG’s insurance brokerage activities, AI-driven health insurance initiatives, and acquisitions in new retail and branding are reflected in its public communications and regulatory announcements. This page can be revisited to see new press releases and Form 6-K summaries as they are issued.
Tian Ruixiang Holdings (NASDAQ: TIRX) announced a 1:50 reverse stock split effective March 16, 2026, and completed due diligence on two transformative deals: a planned 30,000 Bitcoin corporate treasury infusion and the acquisition of an AI-powered insurance brokerage.
Both transactions are targeted to execute and close in Q2–Q3 2026; definitive agreements and closings remain pending.
TIAN RUIXIANG Holdings (Nasdaq: TIRX) announced an expected effective date for its previously approved 1-for-50 reverse stock split. The Company expects the Reverse Split to be effective for trading on Nasdaq during the week of March 16, 2026, pending final Nasdaq processing.
Post-split Class A ordinary shares will trade under the same ticker TIRX, the par value of Class A and Class B shares will increase from $0.125 to $6.25, fractional shares will be rounded up, and the post-split Class A CUSIP will be G8884K144.
Tian Ruixiang Holdings (NASDAQ: TIRX) announced an expanded strategic investment that doubles its planned Bitcoin injection from 15,000 to 30,000 BTC on Feb 26, 2026. The revision, described as a strategic investor commitment, is valued at over $2.0 billion at current market prices and is intended to strengthen the balance sheet and accelerate AI-crypto product development via a joint global innovation lab.
The expanded program targets AI-powered trading, scalable blockchain infrastructure, institutional and retail products, and Layer-2/DeFi/NFT integration to support aggressive expansion and technology acquisitions.
Tian Ruixiang (NASDAQ: TIRX) is in advanced, final-stage talks to combine with a leading Asia-Pacific InsurTech while continuing its previously announced 15,000 BTC acquisition strategy. The deal would use TIRX as the exclusive U.S. public platform, keep existing shareholders public, and aim to attract institutional interest and expanded coverage.
Management says no definitive agreement has been reached and updates will be provided as appropriate.
TIAN RUIXIANG Holdings (Nasdaq: TIRX) reported results of its annual general meeting held February 17, 2026.
Shareholders approved an increase in authorized share capital to US$3,750,000,000 and granted the board authority for a reverse split. The board will implement a 1-for-50 reverse share split; fractional shares will be rounded up. Effective date and new CUSIP will be announced after Nasdaq processes are complete.
Tian Ruixiang Holdings (NASDAQ: TIRX) announced strategic partnership and acquisition discussions with Singapore’s top three medical technology leaders, aiming to complete transactions within 12 months. The plan integrates proprietary AI diagnostics into a pan‑Asia insurance‑clinic network, targeting 95%+ diagnostic accuracy, automating 70% of routine workflows, and reducing operational costs by 40%+.
The transactions are subject to customary closing conditions, including regulatory approvals and shareholder consent, and include no disclosed deal values.
TIAN RUIXIANG (NASDAQ: TIRX) announced a dual initiative: a 15,000 BTC strategic alliance formed Feb 3, 2026, plus a binding agreement to acquire an APRA-regulated Australian bank with $200 billion in assets. The company says the BTC reserve will back an ASEAN-focused, AI‑fortified stablecoin and the bank will provide fiat rails, regulatory credibility, and nationwide branch infrastructure. The release cites preliminary regulatory sign-off in Australia and targets acquisition close by Q3 2026 with a phased stablecoin launch across ASEAN in H2 2026. Forward-looking risks include regulatory, integration, and market uncertainties.
TIAN RUIXIANG (NASDAQ: TIRX) announced a strategic alliance backed by a 15,000 BTC injection and said it is in the final negotiation phase with regulators and government leaders across Indonesia, Malaysia, Singapore, and Thailand to launch a government‑backed, fiat‑basket pegged stablecoin.
The company plans a phased rollout targeted for second half of 2026, with an AI‑driven compliance and risk‑management backbone and transparent reserve practices to meet AML/CTF and Travel Rule expectations.
Tian Ruixiang Holdings (NASDAQ: TIRX) announced the TIRX AI Strategic Initiative on February 4, 2026, a multi‑billion‑dollar ecosystem targeting insurance and broker firms with generative AI, predictive analytics, autonomous operations and healthcare intelligence.
The company cites custom LLMs, automation of up to 90% routine work, claimed 40% operational cost reductions, a healthcare suite with 95% accuracy, and analyst projections of 300% YoY AI revenue growth by 2027.
TIAN RUIXIANG (Nasdaq: TIRX) announced a strategic partnership and equity transaction on February 3, 2026 to receive 15,000 BTC (approximately USD1.5 billion) from a global digital asset investor in exchange for an equity stake. The deal funds a joint global innovation lab to develop AI-crypto products, trading and risk systems, blockchain infrastructure, DeFi/NFT solutions, and layer-2 integrations. Management says the BTC injection will strengthen the balance sheet, accelerate R&D, and support global expansion while the agreement formalizes deep collaboration across AI and cryptocurrency ecosystems.